Loss of the p53/p63 regulated desmosomal protein perp promotes tumorigenesis

PLoS Genetics

Volumn 6, Issue 10, 2010, Pages 1-16

  Beaudry, Veronica G ^a   Jiang, Dadi ^a   Dusek, Rachel L ^a   Park, Eunice J ^a   Knezevich, Stevan ^a   Ridd, Katie ^b   Vogel, Hannes ^a   Bastian, Boris C ^b   Attardi, Laura D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; PROTEIN PERP; UNCLASSIFIED DRUG; CADHERIN; MEMBRANE PROTEIN; PERP PROTEIN, HUMAN; PERP PROTEIN, MOUSE; PHOSPHOPROTEIN; PROTEIN P53; TRANSACTIVATOR PROTEIN; TRP63 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL ADHESION; CELL DIFFERENTIATION; CONTROLLED STUDY; DESMOSOME; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INACTIVATION; GENE LOSS; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION; 129 MOUSE; ANIMAL; C57BL MOUSE; CELL CULTURE; DNA MICROARRAY; FEMALE; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; RADIATION EXPOSURE; SKIN; SKIN TUMOR; TISSUE MICROARRAY; TUMOR SUPPRESSOR GENE;

MUS;

ANIMALS; APOPTOSIS; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; DESMOSOMES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; SKIN; SKIN NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 78449242874     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1001168     Document Type: Article

References (90)

1. Cooper GM (1995) Oncogenes. Boston: Jones and Bartlett Publishers. xv, 384 p.
2. Alam M, Ratner D (2001) Cutaneous squamous-cell carcinoma. N Engl J Med 344: 975-983.
3. Hunter KD, Parkinson EK, Harrison PR (2005) Profiling early head and neck cancer. Nat Rev Cancer 5: 127-135.
4. Fuchs E, Raghavan S (2002) Getting under the skin of epidermal morphogenesis. Nat Rev Genet 3: 199-209.
5. Green KJ, Gaudry CA (2000) Are desmosomes more than tethers for intermediate filaments? Nat Rev Mol Cell Biol 1: 208-216.
6. Yin T, Green KJ (2004) Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol 15: 665-677.
7. Chidgey M (2002) Desmosomes and disease: an update. Histol Histopathol 17: 1179-1192.
8. Nose A, Nagafuchi A, Takeichi M (1988) Expressed recombinant cadherins mediate cell sorting in model systems. Cell 54: 993-1001.
9. Nagafuchi A, Shirayoshi Y, Okazaki K, Yasuda K, Takeichi M (1987) Transformation of cell adhesion properties by exogenously introduced Ecadherin cDNA. Nature 329: 341-343.
10. Ozawa M, Baribault H, Kemler R (1989) The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 8: 1711-1717.
11. Rimm DL, Koslov ER, Kebriaei P, Cianci CD, Morrow JS (1995) Alpha 1(E)- catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci U S A 92: 8813-8817.
12. Vleminckx K, Vakaet L Jr., Mareel M, Fiers W, van Roy F (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119.
13. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, et al. (1991) E-cadherinmediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185.
14. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, et al. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89.
15. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, et al. (2005) The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8: 197-209.
16. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, et al. (1991) E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 51: 6328-6337.
17. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193.
18. Derksen PW, Liu X, Saridin F, van der Gulden H, Zevenhoven J, et al. (2006) Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10: 437-449.
19. Davis MA, Reynolds AB (2006) Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland. Dev Cell 10: 21-31.
20. Perez-Moreno M, Song W, Pasolli HA, Williams SE, Fuchs E (2008) Loss of p120 catenin and links to mitotic alterations, inflammation, and skin cancer. Proc Natl Acad Sci U S A 105: 15399-15404.
21. Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E (2001) Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell 104: 605-617.
22. Kobielak A, Fuchs E (2006) Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. Proc Natl Acad Sci U S A 103: 2322-2327.
23. Chitaev NA, Troyanovsky SM (1997) Direct Ca2+-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion. J Cell Biol 138: 193-201.
24. Tselepis C, Chidgey M, North A, Garrod D (1998) Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci U S A 95: 8064-8069.
25. Syed SE, Trinnaman B, Martin S, Major S, Hutchinson J, et al. (2002) Molecular interactions between desmosomal cadherins. Biochem J 362: 317-327.
26. Mathur M, Goodwin L, Cowin P (1994) Interactions of the cytoplasmic domain of the desmosomal cadherin Dsg1 with plakoglobin. J Biol Chem 269: 14075-14080.
27. Troyanovsky SM, Troyanovsky RB, Eshkind LG, Leube RE, Franke WW (1994) Identification of amino acid sequence motifs in desmocollin, a desmosomal glycoprotein, that are required for plakoglobin binding and plaque formation. Proc Natl Acad Sci U S A 91: 10790-10794.
28. Hatzfeld M, Haffner C, Schulze K, Vinzens U (2000) The function of plakophilin 1 in desmosome assembly and actin filament organization. J Cell Biol 149: 209-222.
29. Chen X, Bonne S, Hatzfeld M, van Roy F, Green KJ (2002) Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta -catenin signaling. J Biol Chem 277: 10512-10522.
30. Bonne S, Gilbert B, Hatzfeld M, Chen X, Green KJ, et al. (2003) Defining desmosomal plakophilin-3 interactions. J Cell Biol 161: 403-416.
31. Kowalczyk AP, Hatzfeld M, Bornslaeger EA, Kopp DS, Borgwardt JE, et al. (1999) The head domain of plakophilin-1 binds to desmoplakin and enhances its recruitment to desmosomes. Implications for cutaneous disease. J Biol Chem 274: 18145-18148.
32. Kowalczyk AP, Bornslaeger EA, Borgwardt JE, Palka HL, Dhaliwal AS, et al. (1997) The amino-terminal domain of desmoplakin binds to plakoglobin and clusters desmosomal cadherin-plakoglobin complexes. J Cell Biol 139: 773-784.
33. Bornslaeger EA, Corcoran CM, Stappenbeck TS, Green KJ (1996) Breaking the connection: displacement of the desmosomal plaque protein desmoplakin from cell-cell interfaces disrupts anchorage of intermediate filament bundles and alters intercellular junction assembly. J Cell Biol 134: 985-1001.
34. Green KJ, Simpson CL (2007) Desmosomes: new perspectives on a classic. J Invest Dermatol 127: 2499-2515.
35. Yashiro M, Nishioka N, Hirakawa K (2006) Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma. Eur J Cancer 42: 2397-2403.
36. Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, et al. (2005) An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37: 182-186.
37. Papagerakis S, Shabana AH, Pollock BH, Papagerakis P, Depondt J, et al. (2009) Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer. Hum Pathol 40: 1320-1329.
38. Depondt J, Shabana AH, Florescu-Zorila S, Gehanno P, Forest N (1999) Downregulation of desmosomal molecules in oral and pharyngeal squamous cell carcinomas as a marker for tumour growth and distant metastasis. Eur J Oral Sci 107: 183-193.
39. Furukawa C, Daigo Y, Ishikawa N, Kato T, Ito T, et al. (2005) Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res 65: 7102-7110.
40. Chen YJ, Chang JT, Lee L, Wang HM, Liao CT, et al. (2007) DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene 26: 467-476.
41. Kurzen H, Munzing I, Hartschuh W (2003) Expression of desmosomal proteins in squamous cell carcinomas of the skin. J Cutan Pathol 30: 621-630.
42. Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, et al. (2000) PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/ gas3 family. Genes Dev 14: 704-718.
43. Ihrie RA, Marques MR, Nguyen BT, Horner JS, Papazoglu C, et al. (2005) Perp is a p63-regulated gene essential for epithelial integrity. Cell 120: 843-856.
44. Jiang W, Ananthaswamy HN, Muller HK, Kripke ML (1999) p53 protects against skin cancer induction by UV-B radiation. Oncogene 18: 4247-4253.
45. Indra AK, Li M, Brocard J, Warot X, Bornert JM, et al. (2000) Targeted somatic mutagenesis in mouse epidermis. Horm Res 54: 296-300.
46. Metzger D, Li M, Chambon P (2005) Targeted somatic mutagenesis in the mouse epidermis. Methods Mol Biol 289: 329-340.
47. Ihrie RA, Reczek E, Horner JS, Khachatrian L, Sage J, et al. (2003) Perp is a mediator of p53-dependent apoptosis in diverse cell types. Curr Biol 13: 1985-1990.
48. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, et al. (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94: 339-352.
49. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, et al. (2001) Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410: 549-554.
50. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, et al. (1994) Sunburn and p53 in the onset of skin cancer. Nature 372: 773-776.
51. Bornslaeger EA, Godsel LM, Corcoran CM, Park JK, Hatzfeld M, et al. (2001) Plakophilin 1 interferes with plakoglobin binding to desmoplakin, yet together with plakoglobin promotes clustering of desmosomal plaque complexes at cellcell borders. J Cell Sci 114: 727-738.
52. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
53. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
54. Blumberg H, Dinh H, Trueblood ES, Pretorius J, Kugler D, et al. (2007) Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med 204: 2603-2614.
55. Gebhardt C, Nemeth J, Angel P, Hess J (2006) S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 72: 1622-1631.
56. Salama I, Malone PS, Mihaimeed F, Jones JL (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34: 357-364.
57. Eurich K, Segawa M, Toei-Shimizu S, Mizoguchi E (2009) Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells. World J Gastroenterol 15: 5249-5259.
58. Beider K, Abraham M, Begin M, Wald H, Weiss ID, et al. (2009) Interaction between CXCR4 and CCL20 pathways regulates tumor growth. PLoS One 4: e5125. doi:10.1371/journal.pone.0005125.
59. Hasan L, Mazzucchelli L, Liebi M, Lis M, Hunger RE, et al. (2006) Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing. J Immunol 176: 6512-6522.
60. Punj V, Matta H, Schamus S, Yang T, Chang Y, et al. (2009) Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation. Blood 113: 5660-5668.
61. Ben-Baruch A (2006) The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 25: 357-371.
62. O'Shea JJ, Murray PJ (2008) Cytokine signaling modules in inflammatory responses. Immunity 28: 477-487.
63. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140: 883-899.
64. Pinkus GS, Pinkus JL (1991) Myeloperoxidase: a specific marker for myeloid cells in paraffin sections. Mod Pathol 4: 733-741.
65. Ribatti D, Vacca A, Nico B, Crivellato E, Roncali L, et al. (2001) The role of mast cells in tumour angiogenesis. Br J Haematol 115: 514-521.
66. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, et al. (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13: 1382-1397.
67. Ch'ng S, Wallis RA, Yuan L, Davis PF, Tan ST (2006) Mast cells and cutaneous malignancies. Mod Pathol 19: 149-159.
68. Meininger CJ (1995) Mast cells and tumor-associated angiogenesis. Chem Immunol 62: 239-257.
69. Maltby S, Khazaie K, McNagny KM (2009) Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta 1796: 19-26.
70. Bashkin P, Razin E, Eldor A, Vlodavsky I (1990) Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix. Blood 75: 2204-2212.
71. Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, et al. (1992) Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 12: 112-127.
72. Nava P, Laukoetter MG, Hopkins AM, Laur O, Gerner-Smidt K, et al. (2007) Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell 18: 4565-4578.
73. Dusek RL, Getsios S, Chen F, Park JK, Amargo EV, et al. (2006) The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-target that regulates apoptosis in keratinocytes. J Biol Chem 281: 3614-3624
74. Naik E, Michalak EM, Villunger A, Adams JM, Strasser A (2007) Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa. J Cell Biol 176: 415-424.
75. Andreu P, Johansson M, Affara NI, Pucci F, Tan T, et al. (2010) FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 17: 121-134.
76. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, et al. (1996) TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86: 531-542.
77. Pierce AM, Schneider-Broussard R, Gimenez-Conti IB, Russell JL, Conti CJ, et al. (1999) E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol 19: 6408-6414.
78. Marques MR, Horner JS, Ihrie RA, Bronson RT, Attardi LD (2005) Mice lacking the p53/p63 target gene Perp are resistant to papilloma development. Cancer Res 65: 6551-6556.
79. Kemp CJ, Donehower LA, Bradley A, Balmain A (1993) Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74: 813-822.
80. Benjamin CL, Ullrich SE, Kripke ML, Ananthaswamy HN (2008) p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer. Photochem Photobiol 84: 55-62.
81. Bruins W, Zwart E, Attardi LD, Iwakuma T, Hoogervorst EM, et al. (2004) Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389. Mol Cell Biol 24: 8884-8894.
82. Melnikova VO, Ananthaswamy HN (2005) Cellular and molecular events leading to the development of skin cancer. Mutat Res 571: 91-106.
83. Lozano G, Zambetti GP (2005) What have animal models taught us about the p53 pathway? J Pathol 205: 206-220.
84. Hemann MT, Zilfou JT, Zhao Z, Burgess DJ, Hannon GJ, et al. (2004) Suppression of tumorigenesis by the p53 target PUMA. Proc Natl Acad Sci U S A 101: 9333-9338.
85. Armstrong BK, Kricker A (2001) The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63: 8-18.
86. (2009) Detailed Guide: Esophagus Cancer. American Cancer Society.
87. Kashiwagi S, Yashiro M, Takashima T, Nomura S, Noda S, et al. (2010) Significance of E-cadherin expression in triple-negative breast cancer. Br J Cancer 103: 249-255.
88. Mell LK, Meyer JJ, Tretiakova M, Khramtsov A, Gong C, et al. (2004) Prognostic significance of E-cadherin protein expression in pathological stage IIII endometrial cancer. Clin Can Res 10: 5546-5553.
89. Luthra R, Wu TT, Luthra MG, Izzo J, Lopez-Alvarez E, et al. (2006) Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol 24: 259-267.
90. Harradine KA, Ridd K, Saunier EF, Clermont FF, Perez-Losada J, et al. (2009) Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients. Clin Cancer Res 15: 5101-5107.